FOLH1 and prostate cancer: Patients with a Gleason score of 6 or 7 showed a lower median SUVmax than patients with a Gleason score of >7 and patients with a PSA level <10.0 ng/ml a lower median SUVmax than those with PSA level >10.0 ng/ml, suggesting the value of 68Ga-PSMA PET in initial staging in patients with high-risk prostate cancer.